TRONOX LIMITED CL A ORDINARY SHARES · Healthcare · Chemicals
As of 2026-06-26, TRONOX LIMITED CL A ORDINARY SHARES (TROX) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.4%, relative volume 1.66×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
13 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TROX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $36M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $36M |
| VXFVanguard Extended Market ETF | 0.02% | $13M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TROX Jan avg: 17.45% median: 13.54% win: 75% σ: 22.19% n: 4 2022-04-12 → 2026-05-29 | TROX Feb avg: -0.86% median: -1.22% win: 50% σ: 20.56% n: 4 2022-04-12 → 2026-05-29 | TROX Mar avg: 7.89% median: 5.10% win: 50% σ: 19.67% n: 4 2022-04-12 → 2026-05-29 | TROX Apr avg: -7.34% median: -4.80% win: 20% σ: 9.73% n: 5 2022-04-12 → 2026-05-29 | TROX May avg: -3.28% median: 4.71% win: 60% σ: 17.19% n: 5 2022-04-12 → 2026-05-29 | TROX Jun avg: -4.70% median: -8.73% win: 25% σ: 17.16% n: 4 2022-04-12 → 2026-05-29 (current) | TROX Jul avg: -9.15% median: -2.04% win: 50% σ: 19.32% n: 4 2022-04-12 → 2026-05-29 | TROX Aug avg: 4.18% median: -1.82% win: 50% σ: 21.09% n: 4 2022-04-12 → 2026-05-29 | TROX Sep avg: -4.70% median: -3.77% win: 25% σ: 8.96% n: 4 2022-04-12 → 2026-05-29 | TROX Oct avg: -13.15% median: -15.05% win: 0% σ: 8.02% n: 4 2022-04-12 → 2026-05-29 | TROX Nov avg: 13.79% median: 18.02% win: 75% σ: 9.32% n: 4 2022-04-12 → 2026-05-29 | TROX Dec avg: -1.99% median: -1.12% win: 50% σ: 11.51% n: 4 2022-04-12 → 2026-05-29 |